{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:23:16Z","timestamp":1785511396533,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T00:00:00Z","timestamp":1450137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T00:00:00Z","timestamp":1450137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Atopic dermatitis (AD) is a complex skin disease primarily characterized by psoriasis of the stratum corneum. AD drugs have usually been used in acidic and hydrophilic solvents to supply moisture and prevent lipid defects. Ceramide is a typical treatment agent to regenerate the stratum corneum and relieve symptoms of AD. However, ceramide has limitation on direct use for skin because of its low dispersion properties in hydrophilic phase and side effects at excessive treatment. In this study, ceramide imbedded PLGA nanoparticles were developed with chitosan coating (Chi-PLGA\/Cer) to overcome this problem. The chitosan coating enhanced initial adherence to the skin and prevented the initial burst of ceramide, but was degraded by the weakly acidic nature of skin, resulting in controlled release of ceramide with additional driving force of the squeezed PLGA nanoparticles. Additionally, the coating kinetics of chitosan were controlled by manipulating the reaction conditions and then mathematically modeled. The Chi-PLGA\/Cer was not found to be cytotoxic and ceramide release was controlled by pH, temperature and chitosan coating. Finally, Chi-PLGA\/Cer was demonstrated to be effective at stratum corneum regeneration in a rat AD model. Overall, the results presented herein indicated that Chi-PLGA\/Cer is a novel nanodrug for treatment of AD.<\/jats:p>","DOI":"10.1038\/srep18089","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T09:41:41Z","timestamp":1450172501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Thermodynamic Insights and Conceptual Design of Skin-Sensitive Chitosan Coated Ceramide\/PLGA Nanodrug for Regeneration of Stratum Corneum on Atopic Dermatitis"],"prefix":"10.1038","volume":"5","author":[{"given":"Sang-Myung","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwang Heum","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoo Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Hee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Il","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ju","family":"Yeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seul Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeo Seon","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Ha","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa Sung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,15]]},"reference":[{"key":"BFsrep18089_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/1523-1747.ep12265510","volume":"84","author":"PW Wertz","year":"1985","unstructured":"Wertz, P. W. et al. The composition of the ceramides from human stratum corneum and from comedones. J Invest Dermatol 84, 410\u2013412 (1985).","journal-title":"J Invest Dermatol"},{"key":"BFsrep18089_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/00015559850135788","volume":"78","author":"A Di Nardo","year":"1998","unstructured":"Di Nardo, A. et al. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol(stockh) 78, 27\u201330 (1998).","journal-title":"Acta Derm Venereol(stockh)"},{"key":"BFsrep18089_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/1523-1747.ep12470233","volume":"96","author":"G Imokawa","year":"1991","unstructured":"Imokawa, G. et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 96, 523\u2013526 (1991).","journal-title":"J Invest Dermatol"},{"key":"BFsrep18089_CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/CDLI.6.1.101-104.1999","volume":"6","author":"Y Ohnishi","year":"1999","unstructured":"Ohnishi, Y. et al. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis. Clin Diagn Lab Immun 6, 101\u2013104 (1999).","journal-title":"Clin Diagn Lab Immun"},{"key":"BFsrep18089_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1046\/j.1523-1747.2002.01836.x","volume":"119","author":"S Hamanaka","year":"2002","unstructured":"Hamanaka, S. et al. Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. J Invest Dermatol 119, 416\u2013423 (2002).","journal-title":"J Invest Dermatol"},{"key":"BFsrep18089_CR6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s004030050409","volume":"291","author":"S Pillai","year":"1999","unstructured":"Pillai S. et al. Ceramide potentiates, but sphingomyelin inhibits, vitamin D-induced keratinocyte differentiation: comparison between keratinocytes and HL-60 cells. Arch Dermatol Res 291, 284\u2013289 (1999).","journal-title":"Arch Dermatol Res"},{"key":"BFsrep18089_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1124\/mi.5.6.8","volume":"5","author":"NF Lamour","year":"2005","unstructured":"Lamour, N. F. & Chalfant, C. E. Ceramide-1-phosphate: the \u201cmissing\u201d link in eicosanoid biosynthesis and inflammation. Mol Interv 5, 358 (2005).","journal-title":"Mol Interv"},{"key":"BFsrep18089_CR8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nm1748","volume":"14","author":"V Teichgr\u00e4ber","year":"2008","unstructured":"Teichgr\u00e4ber, V. et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 14, 382\u2013391 (2008).","journal-title":"Nat Med"},{"key":"BFsrep18089_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3346\/jkms.2006.21.1.95","volume":"21","author":"B-L Lew","year":"2006","unstructured":"Lew, B.-L. et al. Ceramides and cell signaling molecules in psoriatic epidermis: reduced levels of ceramides, PKC-\u03b1 and JNK. J Korean Med Sci 21, 95\u201399 (2006).","journal-title":"J Korean Med Sci"},{"key":"BFsrep18089_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/cod.12103","volume":"69","author":"Schliemann","year":"2013","unstructured":"Schliemann. et al. Protective creams fail to prevent solvent\u2010induced cumulative skin irritation\u2013results of a randomized double\u2010blind study. Contact Derm 69, 363\u2013371 (2013).","journal-title":"Contact Derm"},{"key":"BFsrep18089_CR11","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/jcm4050970","volume":"4","author":"DJ Panther","year":"2015","unstructured":"Panther, D. J. et al. The Importance of Acidification in Atopic Eczema: An Underexplored Avenue for Treatment. J Clin Med 4, 970\u2013978 (2015).","journal-title":"J Clin Med"},{"key":"BFsrep18089_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4142\/jvs.2013.14.2.199","volume":"14","author":"JY Jung","year":"2013","unstructured":"Jung, J. Y. et al. Clinical use of a ceramide-based moisturizer for treating dogs with atopic dermatitis. J Vet Sci 14, 199\u2013205 (2013).","journal-title":"J Vet Sci"},{"key":"BFsrep18089_CR13","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia, H. K. & Siegel, S. J. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 3, 1377\u20131397 (2011).","journal-title":"Polymers"},{"key":"BFsrep18089_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1586\/erm.09.15","volume":"9","author":"J-M L\u00fc","year":"2009","unstructured":"L\u00fc, J.-M. et al. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn 9, 325\u2013341(2009).","journal-title":"Expert Rev Mol Diagn"},{"key":"BFsrep18089_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ijpharm.2008.04.042","volume":"364","author":"C Wischke","year":"2008","unstructured":"Wischke, C. et al. Principles of encapsulating hydrophobic drugs in PLA\/PLGA microparticles. International Journal of pharmaceutics 364, 298\u2013327 (2008).","journal-title":"International Journal of pharmaceutics"},{"key":"BFsrep18089_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0939-6411(00)00062-X","volume":"50","author":"RA Jain","year":"2000","unstructured":"Jain, R. A. et al. Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables. Eur J Pharm Biopharm 50, 257\u2013262 (2000).","journal-title":"Eur J Pharm Biopharm"},{"key":"BFsrep18089_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jbm.b.31243","volume":"89","author":"L Nikkola","year":"2009","unstructured":"Nikkola, L. et al. Temporal control of drug release from biodegradable polymer: multicomponent diclofenac sodium releasing PLGA 80\/20 rod. J Biomed Mater Res Part B Appl Biomater 89, 518\u2013526 (2009).","journal-title":"J Biomed Mater Res Part B Appl Biomater"},{"key":"BFsrep18089_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1517\/17425247.5.6.615","volume":"5","author":"SD Allison","year":"2008","unstructured":"Allison, S. D. Analysis of initial burst in PLGA microparticles. Expert Opin Drug Deliv 5, 615\u2013625 (2008).","journal-title":"Expert Opin Drug Deliv"},{"key":"BFsrep18089_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1142\/S0256767908002674","volume":"26","author":"Y-j Liu","year":"2008","unstructured":"Liu, Y.-j. et al. Control of dimensional stability and degradation rate in electrospun composite scaffolds composed of poly (d, l-lactide-co-glycolide) and poly (\u03b5-caprolactone).Chin J Polym Sci 26, 63\u201371 (2008).","journal-title":"Chin J Polym Sci"},{"key":"BFsrep18089_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2009.09.004","volume":"62","author":"T Kean","year":"2010","unstructured":"Kean, T. & Thanou, M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Delivery Rev 62, 3\u201311 (2010).","journal-title":"Adv Drug Delivery Rev"},{"key":"BFsrep18089_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/12_2011_137","volume":"244","author":"R Raphael","year":"2011","unstructured":"Raphael, R. et al. J. Chitosan and Chitosan Derivatives in Drug Delivery and Tissue Engineering. Adv Polym Sci 244 19\u201344 (2011).","journal-title":"Adv Polym Sci"},{"key":"BFsrep18089_CR22","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/0142-9612(95)98126-Y","volume":"16","author":"KY Lee","year":"1995","unstructured":"Lee, K. Y. et al. Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. Biomaterials 16, 1211\u20131216 (1995).","journal-title":"Biomaterials"},{"key":"BFsrep18089_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.colsurfb.2012.10.063","volume":"103","author":"L Chronopoulou","year":"2013","unstructured":"Chronopoulou, L. et al. Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures. Colloids Surf B 103, 310\u2013317 (2013).","journal-title":"Colloids Surf B"},{"key":"BFsrep18089_CR24","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1021\/bm700453x","volume":"8","author":"P Wydro","year":"2007","unstructured":"Wydro, P. et al. Chitosan as a lipid binder: a langmuir monolayer study of chitosan-lipid interactions. Biomacromolecules 8, 2611\u20132617 (2007).","journal-title":"Biomacromolecules"},{"key":"BFsrep18089_CR25","first-page":"277","volume":"3","author":"EA El-hefian","year":"2009","unstructured":"El-hefian, E. A. et al. Surface investigation of chitosan film with fatty acid monolayers. Maejo Int J Sci Tech 3, 277\u2013286 (2009).","journal-title":"Maejo Int J Sci Tech"},{"key":"BFsrep18089_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0168-3659(02)00127-X","volume":"82","author":"SK Sahoo","year":"2002","unstructured":"Sahoo, S. K. et al. Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 82, 105\u2013114 (2002).","journal-title":"J Control Release"},{"key":"BFsrep18089_CR27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jmbbm.2011.08.006","volume":"5","author":"A Aryaei","year":"2012","unstructured":"Aryaei, A. et al. Nano and micro mechanical properties of uncross-linked and cross-linked chitosan films. J Mech Behav Biomed Mater 5, 82\u201389 (2012).","journal-title":"J Mech Behav Biomed Mater"},{"key":"BFsrep18089_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ejpb.2008.06.008","volume":"70","author":"C Guo","year":"2008","unstructured":"Guo, C. & Gemeinhart, R. A. Understanding the adsorption mechanism of chitosan onto poly (lactide-co-glycolide) particles. Eur J Pharm Biopharm 70, 597\u2013604 (2008).","journal-title":"Eur J Pharm Biopharm"},{"key":"BFsrep18089_CR29","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1021\/ed003p1454.2","volume":"3","author":"MM Haring","year":"1926","unstructured":"Haring, M. M. Colloid and Capillary Chemistry (Freundlich, Herbert). J Chem Educ 3, 1454 (1926).","journal-title":"J Chem Educ"},{"key":"BFsrep18089_CR30","first-page":"242","volume":"19","author":"T Knor","year":"2010","unstructured":"Knor, T. et al. Stratum corneum hydration and skin surface pH in patients with atopic dermatitis. Acta Dermatovenerol Croat: ADC 19, 242\u2013247 (2010).","journal-title":"Acta Dermatovenerol Croat: ADC"},{"key":"BFsrep18089_CR31","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1021\/j150292a011","volume":"32","author":"S Mattson","year":"1928","unstructured":"Mattson, S. Cataphoresis and the Electrical Neutralization of Colloidal Material. J Phys Chem 32, 1532\u20131552 (1928).","journal-title":"J Phys Chem"},{"key":"BFsrep18089_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.addr.2012.09.032","volume":"64","author":"AC Williams","year":"2012","unstructured":"Williams A. C. & Barry B. W. Penetration enhancers. Adv Drug Deliv Rev. 64, 128\u2013137 (2012).","journal-title":"Adv Drug Deliv Rev."},{"key":"BFsrep18089_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/CCID.S5758","volume":"2","author":"L Kowalzick","year":"2009","unstructured":"Kowalzick, L. Novel topical therapy for mild-to-moderate plaque psoriasis: focus on calcitriol. Clin Cosmet Investig Dermatol: CCID 2, 153 (2009).","journal-title":"Clin Cosmet Investig Dermatol: CCID"},{"key":"BFsrep18089_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/ACI.0b013e32830e6fb2","volume":"8.5","author":"GM O\u2019Regan","year":"2008","unstructured":"O\u2019Regan, G. M. & Alan D. I. The role of filaggrin loss-of-function mutations in atopic dermatitis. Curr Opin Allergy Clin Immunol 8.5, 406\u2013410 (2008).","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"BFsrep18089_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1517\/13543770902755129","volume":"19","author":"M Xia","year":"2009","unstructured":"Xia M. & Sui Z. Recent developments in CCR2 antagonists. Expert Opin Ther Pat. 19, 295\u2013303 (2009)","journal-title":"Expert Opin Ther Pat."},{"key":"BFsrep18089_CR36","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1021\/ja02268a002","volume":"38","author":"I Langmuir","year":"1916","unstructured":"Langmuir, I. The constitution and fundamental properties of solids and liquids. part i. solids. J Am Chem Soc 38, 2221\u20132295 (1916).","journal-title":"J Am Chem Soc"},{"key":"BFsrep18089_CR37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1021\/ja01269a023","volume":"60","author":"S Brunauer","year":"1938","unstructured":"Brunauer, S. et al. Adsorption of gases in multimolecular layers. J Am Chem Soc 60, 309\u2013319 (1938).","journal-title":"J Am Chem Soc"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep18089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep18089","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep18089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T20:28:29Z","timestamp":1672950509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep18089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,15]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,22]]}},"alternative-id":["BFsrep18089"],"URL":"https:\/\/doi.org\/10.1038\/srep18089","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,15]]},"assertion":[{"value":"17 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18089"}}